BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 31273053)

  • 1. Characterization of Copy Number Variations in Oral Cavity Squamous Cell Carcinoma Reveals a Novel Role for MLLT3 in Cell Invasiveness.
    Wang CI; Kao HK; Chen TW; Huang Y; Cheng HW; Yi JS; Hung SY; Wu CS; Lee YS; Chang KP
    Oncologist; 2019 Dec; 24(12):e1388-e1400. PubMed ID: 31273053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
    Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
    Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
    Liu M; Gao X; Liu CL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
    Ji L; Zhu ZN; He CJ; Shen X
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma.
    Inoue K; Hatano K; Hanamatsu Y; Saigo C; Kito Y; Bunai K; Shibata T; Takeuchi T
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):851-859. PubMed ID: 30635792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6.
    Wang X; Chang K; Gao J; Wei J; Xu G; Xiao L; Song G
    Int J Biochem Cell Biol; 2020 Feb; 119():105663. PubMed ID: 31812760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-373 promotes proliferation and metastasis of oral squamous cell carcinoma by targeting SPOP.
    Zhang XJ; Jin Y; Song JL; Deng F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5270-5276. PubMed ID: 31298378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
    Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-610 functions as a tumor suppressor in oral squamous cell carcinoma by directly targeting AGK.
    Yao LX; Liu J; Xu L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):187-197. PubMed ID: 30657560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1α Regulates Proliferation and Invasion of Oral Cancer Cells through Kv3.4 Channel.
    Qian C; Dai Y; Xu X; Jiang Y
    Ann Clin Lab Sci; 2019 Sep; 49(4):457-467. PubMed ID: 31471334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of RNase 7 in the malignant potential of oral squamous cell carcinoma cells.
    Neopane P; Kurashige Y; Yoshida K; Uehara O; Paudel D; Morikawa T; Sato J; Saitoh M; Abiko Y
    Oncol Rep; 2020 Sep; 44(3):1216-1223. PubMed ID: 32705284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy Number Variation That Influences the Ionizing Radiation Sensitivity of Oral Squamous Cell Carcinoma.
    Izumi T; Rychahou P; Chen L; Smith MH; Valentino J
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
    Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
    Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
    J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA6‑induced FN1 activation promotes the proliferation, invasion and migration of oral squamous cell carcinoma cells.
    Zhai J; Luo G
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35088888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-625-3p promotes cell migration of oral squamous cell carcinoma by regulating SCAI expression.
    Xu D; Gu M; Liu HL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):641-648. PubMed ID: 30720172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC2 promotes cell migration/invasion abilities through HIF-1α stabilization in human oral squamous cell carcinoma.
    Chang CC; Lin BR; Chen ST; Hsieh TH; Li YJ; Kuo MY
    J Oral Pathol Med; 2011 Aug; 40(7):567-75. PubMed ID: 21332579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of copy number alternation profiles in metastatic oral squamous carcinoma patients by using microarray-based comparative genomic hybridization: A study on Turkish patients.
    Unur M; Cincin ZB; Tanıs T; Kayhan KB; Ulusan M; Bireller S; Cakmakoglu B
    J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101583. PubMed ID: 37532081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.